BDSX vs XGN: stock comparison and AI forecast
Biodesix Inc (BDSX) and Exagen Inc. (XGN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BDSX Biodesix Inc
- Market Cap
- $222M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
XGN Exagen Inc.
- Market Cap
- $203M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BDSX and XGN have similar market capitalizations ($222M and $203M).
- XGN turns -26.6% of its revenue into net income, against -27.0% for BDSX.
- BDSX carries 9.42 times debt per unit of equity, against 3.25 times for XGN.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BDSX | XGN |
|---|---|---|
| Market Cap | $222M | $203M |
| P/B Ratio | 24.29x | 16.64x |
| EPS | $-2.18 | $-0.85 |
| Book Value/Share | $0.87 | $0.50 |
| Revenue/Share | $9.76 | $2.94 |
| FCF/Share | $-1.92 | $-0.31 |
Profitability & Margins
| Metric | BDSX | XGN |
|---|---|---|
| ROE | -303.6% | -154.9% |
| ROA | -29.1% | -36.4% |
| ROIC | -25.8% | -34.3% |
| Gross Margin | – | 58.6% |
| Operating Margin | -20.0% | -18.6% |
| Net Margin | -27.0% | -26.6% |
| EBT Margin | -20.0% | -18.6% |
| Tax Rate | 0.0% | -0.4% |
Financial Health
| Metric | BDSX | XGN |
|---|---|---|
| Current Ratio | 2.85x | 3.18x |
| D/E Ratio | 9.42x | 3.25x |
| Financial Leverage | 10.42x | 4.25x |
| Interest Coverage | -2.7x | -2.0x |
| Working Capital | $28M | $29M |
Cash Flow
| Metric | BDSX | XGN |
|---|---|---|
| Operating Cash Flow | -$20M | -$6M |
| Free Cash Flow | -$20M | -$8M |
| Capital Spending | -$410K | -$1M |
| FCF/Sales | -19.7% | -10.7% |
| CapEx/Sales | 0.4% | 1.5% |
Operational Efficiency
| Metric | BDSX | XGN |
|---|---|---|
| Asset Turnover | 1.08x | 1.37x |
| Receivables Turnover | 11.3x | 5.7x |
| Fixed Assets Turnover | 4.3x | 10.8x |
| Days Sales Outstanding | 32 days | 64 days |
| Payables Period | – | 55 days |
Income Statement
| Metric | BDSX | XGN |
|---|---|---|
| Total Revenue | $103M | $71M |
| Operating Income | -$21M | -$13M |
| Net Income | -$28M | -$19M |
| R&D Expense | $12M | $6M |
| SG&A Expense | $93M | $48M |
| Cost of Goods Sold | – | $29M |
Dividend & Shareholder Information
| Metric | BDSX | XGN |
|---|---|---|
| Shares Outstanding | 11M | 24M |
BDSX vs XGN: stock comparison and AI forecast
Which is bigger, BDSX or XGN?
BDSX and XGN have similar market capitalizations ($222M and $203M).
Which one does Intratio's AI model rank higher, BDSX or XGN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.